Spravato® Therapy
Spravato® (esketamine) is an FDA-approved treatment for adults with treatment-resistant depression and for depressive symptoms associated with suicidal thoughts. Treatment is administered on-site under medical supervision and follows strict FDA and REMS guidelines.
Spravato may be an appropriate option for individuals seeking an insurance-covered treatment with structured protocols and clinical oversight.